Considerations for Developing Scalable and Efficient Collection Network Processes

On-demand webinar offers actionable insights as you develop your protocols.

Many crucial considerations impact a cell and gene therapy developer’s apheresis center selection strategy and ability to efficiently scale processes.

When collection processes or protocols differ from those in place at a center, there are likely implications for training, forms and standard operating procedures. This can potentially delay a first collection.

During the on-demand webinar, our panelists discuss:

• Common protocol decisions cell and gene therapy developers make along the product collection pathway that can impact ability to scale
• Specific considerations for collecting starting material for allogeneic cell therapies
• Factors for post-collection transport and processing to ensure efficient delivery of starting material to the manufacturer

PANELISTS

Lacey Anderson
Senior Manager, Collection Network Management
NMDP BioTherapies (formerly Be The Match BioTherapies)

Sara Butler
Network Liaison, Collection Network Management
NMDP BioTherapies (formerly Be The Match BioTherapies)

Allison Montalvo
Program Manager, Oncology
Janssen (A division of J&J)

View Webinar